Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

Why is $ACTU stock down today?

Actuate Therapeutics, Inc. Common stock

Why is $ACTU down today?

The likely driver

Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer
GlobeNewswire Inc.·7:00 AM ETpositive
Price
$1.71
Move today
-7.0%
Volume vs avg
0.0x
Scanner alerts today
0

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.